This updated report, first published in 2012 as “Checking up on Taiwan healthcare,” provides an introductory overview of Taiwan’s health industries—including the healthcare, biotechnology, pharmaceutical and medical device sectors—and examines the future prospects, opportunities and challenges for market participants.
Taiwan boasts one of the most progressive health systems in Asia, but it currently faces a number of pressing healthcare policy challenges, including the impact of a rapidly ageing population and rising healthcare costs.
Healthcare providers and biotech, pharma and medical device companies also face a dynamic operating environment in Taiwan, but one which offers many opportunities for growth across the health spectrum.
PwC’s health industries practice focuses on the healthcare, pharmaceutical and life sciences sectors, and our people bring industry experience as it pertains to audit and assurance, tax and advisory services.
To have a deeper conversation about Taiwan’s health industries market, please contact Lily Wong.